Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ackerley Sports Group (ASG) invests in the sports sector, focusing on leagues, teams, venues & media, technology, and development opportunities. It does not operate in life sciences, biotech, pharma, or healthcare sectors[1][2][3][6].
ASG has a long history of ownership and operation of professional sports franchises across multiple sports and geographies. Recent investments include stakes in Leeds United (in partnership with San Francisco 49ers Enterprises) and TMRW Sports (with Tiger Woods and Rory McIlroy). The group has also been involved with the NBA Seattle SuperSonics, WNBA Seattle Storm, CISL Seattle Seadogs, MLR Seattle Seawolves, AHL Coachella Firebirds, and NHL’s Seattle Kraken[2][3]. In late 2023–2025 it pursued a $75 million investment for a minority stake in South African Rugby's commercial rights company[3][6][7].
There are no clinical results or drug development activities associated with this company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ackerley Sports Group.